These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31077763)

  • 1. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders.
    Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M
    Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
    Leng D; Thanki K; Foged C; Yang M
    Pharm Res; 2018 Nov; 35(12):247. PubMed ID: 30386927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer.
    Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation.
    Lu W; Rades T; Rantanen J; Chan HK; Yang M
    Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
    Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
    Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA.
    Jensen DK; Jensen LB; Koocheki S; Bengtson L; Cun D; Nielsen HM; Foged C
    J Control Release; 2012 Jan; 157(1):141-8. PubMed ID: 21864597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
    Li X; Mansour HM
    AAPS PharmSciTech; 2011 Dec; 12(4):1420-30. PubMed ID: 22038473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalable dry powder formulations of siRNA and pH-responsive peptides with antiviral activity against H1N1 influenza virus.
    Liang W; Chow MY; Lau PN; Zhou QT; Kwok PC; Leung GP; Mason AJ; Chan HK; Poon LL; Lam JK
    Mol Pharm; 2015 Mar; 12(3):910-21. PubMed ID: 25599953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin.
    Chow MYT; Qiu Y; Liao Q; Kwok PCL; Chow SF; Chan HK; Lam JKW
    Int J Pharm; 2019 Dec; 572():118818. PubMed ID: 31678379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation.
    Liang W; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
    Int J Pharm; 2018 Dec; 552(1-2):67-75. PubMed ID: 30244146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman mapping of mannitol/lysozyme particles produced via spray drying and single droplet drying.
    Pajander JP; Matero S; Sloth J; Wan F; Rantanen J; Yang M
    Pharm Res; 2015 Jun; 32(6):1993-2002. PubMed ID: 25504535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
    Grohganz H; Lee YY; Rantanen J; Yang M
    Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.
    Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC
    Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.